 | Medicines Management Board Minutes ELHE 230113 (186 KB) | 22/04/2013 | Download |
| | ELHT Alcohol Pathway approved for website. HIV Formulary - work on-going. VSL#3 for pouchitis - probiotics policy approved for website. Osteoporsis guidelines - awaiting feedback before finalised. ELHE immunoglobulin prescribing and supply SOP - approved for use. laxative guidelines - awaiting final comments. DVt pathway for primary care - awaiting decision on stocking selection before approval. | |
| Medicines Management Board Minutes 6th March 2013 (197 KB) | 19/04/2013 | Download |
| | Omacor - review to go to LMMG for lancs wide agreement.
Formulary recommendations: metolazone - bendro dose for oedema confirmed as 5mg daily with cardiology. Chloramphenicol topical for wounds - other options being explored. HIV formulary - local guidance still going through FCG. ELHT osteoporosis guidelines - awaiting feedback , long term guidance info to go out to GPs. Ivabradine for Chronic Heart Failure - request for guidance fed to LMMG and awaiting feedback from cardiac network. Laxa | |
| Medicines Management Board Minutes ELHE 191212 (208 KB) | 06/02/2013 | Download |
| | New medicines requests: fentanyl short acting (Abstral®)- Black traffic light: Doxorubicin Beads- radiology use only - Red traffic light.
ELHT alcohol pathway - final version to come to MMB for information.
Formulary recommendations - Metolazone - bendroflumethiazide dose for oedema to be confirmed with cardiology at their next meeting. Levetiracetem - can be prescribed generically. Minocycline - for specialist dermatology use only but not for acne.
New product request; Propverine - speciali | |
| Medicines Management Board Minutes ELHE November 2012 (194 KB) | 07/01/2013 | Download |
| | Omacor - review - to be followed up with Cardiac network.
Formulary recommendations - Chloramphenicol topical for wounds. Metolozone - bendromethiazide drug of choice since indapamide only licensed for hypertension.
Levetiracetam - no progress on generic prescribing.
Phenytoin Flynn capsules - well established patients on epanutin caps should comtinue to receive the equivalent product with no recommendation for review.
Minocycline - feedback regarding specific use in dermatology
Carnoys So | |
| Medicines Management Board Minutes East Lancs - 17th October 2012 (134 KB) | 14/12/2012 | Download |
| | Anticoagulant Guidelines in AF.
New Medicine Request - Omalizumab for Urticaria.
HIV Formulary and Eviplera Request.
Ozurdex Repeat dose
Rituximab for SLE and related conditions - updated policy.
Formulary recommendations: metolazone now discontinued, cardiology advice needed to suggest alternative suitable therapy. Antiepileptics exceptions to brand prescribing - agreed to prescribe lamotrigine, gabapentin and topiramate generically. Phenytoin Flynn capsules replacing Epanutin capsules - | |
| Medicines Management Board Minutes 19.09.12 (203 KB) | 26/10/2012 | Download |
| | New Product Request - Diazoxide - on-going.
Omacor - review - remains amber in ELHE at present.
ELHE Type 2 Diabetes Guideline - comments recieved, to be tabled at next meeting.
Formulary Recomendations - durophat toothpaste for patients with head/neck cancer - agreed that can be prescribed for these patients as an exception to the formulary.
New medicine requests:
1. Tobi Podhaler - red traffic light.
2. Bromfenac eye drops - Black traffic light.
3. Uracyst® bladder installation Black tr | |
| Report on Formulary Adherence to NICE October 2012 (98 KB) | 24/10/2012 | Download |
| | | |
| Medicines Management Board Minutes 18th July 2012 (180 KB) | 08/10/2012 | Download |
| | New Product request - Diazoxide - on-going
Formulary Recommendations - durpohat toothpaste - Lancashire Denatl Transformation Board have prioduced a policy recommending prescribing of high fluoride toothpaste as dental prescribing only
Omacor - review - ELHT cardiologists would like omacor to be available for some patients - to remain Amber in ELHE at present.
New medicine Requests - Micafungin, HPMC 2% in balanced salt solution, Ciprofloxacin as ear drops.
Formulary recommendations: - coles | |
| Medicines Management Board Minutes June 2012 (199 KB) | 26/07/2012 | Download |
| | New Medicine Requests - Liothyronine tablets -AMBER Tarffic Light: Dapoxetine - BLACK Traffic Light: Ivabradine for heart failure - GREY Under review. Genital Wart Care Pathway - approved.
Sildenafil/Tadalafil/Vardenafil - GREEN traffic Light.
Rotigotine Patch for Restless Leg Syndrone - BLACK traffic light for Restless Legs.
NICE recommendtaions - Cabazitaxel for prostate cancer is not recommended by NICE - GREY under review.
Rheumatoid Arthritis Biologics Pathway updated and approved for l | |
| Medicines Management Board Minutes 23rd May 2012 (159 KB) | 29/06/2012 | Download |
| | Alemtuzumab for severe relapsing MS: New medicine request - Linagliptin:New medicine request - Methotrexate syringes - licensed product: Formulary recommendations - licensed prepartions available for clonazepam liquid 500mcg/5mL and paracetamol liquid 500mg/5mL; Octasa (mesalazine) included in formualry as an option for treatment: Canakinumab - NOT recommended for use in ELHE. pegloticase - black traffic lighted accepted by MMB: Sodium Oxybate position reamains as not recommended for prescribing | |
| Medicines Management Board Minutes 18th April 2012 (151 KB) | 14/06/2012 | Download |
| | Integrated care pathway for outpatient & home IV treatment of cellulitis: Brand prescribing of morphine and fentanyl: Formulary recommendations: Infliximab for Pyoderma Gangrenosum: NICE recommendations: Insulin Passport - adult patients: Managing medicines on transfer of care ELHE over-arching policy | |
| Medicines Management Board Minutes - 21st March 2012 (126 KB) | 30/04/2012 | Download |
| | New product request - Zolendronic Acid Infusion 5mg, Diazoxide, Rifaximin, Pentoxifylline.
Rituximab for ANCA Vasculitis - updated recommendtaions approved.
Ticagrelor position statement. Formulary Recommendations Asenapine - Black traffic light, Myfortuc Amber Traffic light,. NICE recommendtaions - Pharmalgen - venom anaphylaxis (TAG246) would be specialist use - RED traffic light.
Tocilizumab for RA (TAG247) - remains red traffic light. Exenatide Prolonged release (TAG248) gREEN TRAFFIC LIG | |
